Related Experiment Video
Updated: Aug 6, 2026
09:45
Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
Integrins in drug targeting-RGD templates in toxins
X Lu1, D Lu, M F Scully
1Thrombosis Research Institute, Manresa Road, London, SW3 6LR UK. xlu@tri-london.ac.uk
Current Pharmaceutical Design
|August 22, 2006
Summary
Integrins are cell receptors involved in many processes. RGD-containing toxins act as integrin antagonists, offering potential for targeted drug delivery and therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Integrins are heterodimeric receptors regulating cellular processes like adhesion, migration, and apoptosis.
- The arginine-glycine-aspartic acid (RGD) motif in extracellular matrix proteins and snake venom toxins mediates integrin binding.
- RGD-containing proteins function as potent integrin antagonists, inhibiting platelet aggregation and cell adhesion.
Purpose of the Study:
- To review integrin structure and function.
- To discuss the structural features of disintegrins responsible for their integrin antagonist activity.
- To explore the therapeutic potential of targeting integrins and using RGD as a template for drug delivery.
Main Methods:
- Review of existing literature on integrin biology.
- Analysis of structural and functional studies of RGD-containing toxins and disintegrins.
- Discussion of drug targeting strategies involving integrins.
Main Results:
- Integrin antagonist potency is linked to the RGD motif's position on a flexible loop.
- Amino acid residues near the RGD motif dictate integrin binding specificity and selectivity.
- RGD-containing proteins show promise as therapeutic agents targeting integrins.
Conclusions:
- Understanding integrin-RGD interactions is crucial for developing targeted therapies.
- Integrins represent viable targets for drug delivery systems.
- The RGD motif serves as a valuable template for designing novel therapeutic agents.
Related Concept Videos
01:10Integrins
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:25Selectins
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain, which...
01:25Drug-Receptor Bonds
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...